SECOND OPINION: PHARMA-BACKED REBATE RULE WOULD HIKE SENIOR PREMIUMS, BOOST DRUG COMPANY PROFITS

Big Pharma Wants Implementation of Misguided Policy that Does Nothing to Lower Drug Prices, Increases Manufacturer Pricing Power Big Pharma is unhappy over the prospect of lawmakers repealing the

07-22-2021 Read More

THEY SAID IT! U.S. SENATE JUDICIARY SUBCOMMITTEE HIGHLIGHTS BIG PHARMA’S ANTI-COMPETITIVE PRACTICES

Lawmakers Showcase How Big Pharma’s Patent Abuse Drives Out-of-Control Prescription Drug Prices During a hearing Tuesday before the U.S. Senate Committee on the Judiciary’s Subcommittee on

07-14-2021 Read More

DOSE OF REALITY: LAWMAKERS TO PROBE BIG PHARMA PATENT ABUSE AS INNOVATION EXCUSES CRUMBLE

U.S. Senate Judiciary Subcommittee Hearing Tuesday Will Build on Momentum for Lawmakers to Hold Big Pharma Accountable, Lower Prescription Drug Prices On Tuesday, the U.S. Senate Committee on the

07-13-2021 Read More

CSRxP COMMENDS PRESIDENT BIDEN FOR RENEWED COMMITMENT TO HOLDING BIG PHARMA ACCOUNTABLE

Campaign Looks Forward to Working with Administration and Congress to Crack Down on Anti-Competitive Practices and Lower Rx Price For Immediate Release Contact: Jon Conradi 860-235-3884

07-9-2021 Read More

CSRXP: OVERSIGHT REPORT ADDS TO MOMENTUM IN WASHINGTON TO HOLD BIG PHARMA ACCOUNTABLE

U.S. House Oversight & Reform Committee Report Shines Light on Branded Drugmakers’ Profiteering Practices, Debunks Innovation Rhetoric For Immediate Release Contact: Jon Conradi 860-235-3884

07-8-2021 Read More

BIG PHARMA WATCH: JULY PRICE HIKES CLIMB TO 52

Brand Name Drug Companies Stick to Business-as-Usual in Third Major Round of Pandemic Price Hikes In case you missed it, Big Pharma companies are actively engaged in price hikes on branded

07-7-2021 Read More

CSRxP: Big Pharma Flaunts Disregard for Rx Affordability With Third Major Round of Pandemic Price Hikes

Pharmaceutical Companies Increase Prices on 32 Brand Name Drugs to Start July   For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]   Washington, D.C. – The

07-1-2021 Read More

ICYMI: BIG PHARMA USES INFLUENCE OVER PATIENT GROUPS & ASTROTURF TACTICS TO UNDERMINE RX SOLUTIONS

New Report Reveals “Hidden Hand” Of Brand Name Drug Industry In case you missed it, Patients for Affordable Drugs (P4AD) released a new report Tuesday examining the financial levers and tactics

06-30-2021 Read More

CSRXP APPLAUDS U.S. HOUSE PROBE INTO BIOGEN PRICING OF ADUHELM

Pallone and Maloney Announce Joint Investigation into Massive Price Tag on Unproven Alzheimer’s Treatment as Outrage Builds For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]

06-25-2021 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.